Independent research in Eastern and Southern Africa identifies opportunities to improve effectiveness of Global Fund processes
ABSTRACT
The Health Economics and HIV and AIDS Research Division of the University of Kwazulu-Natal has just published a report synthesizing findings from three country case studies from Eastern and Southern Africa, commissioned by the Bill & Melinda Gates Foundation, as part of its work to support initiatives improving the impact of HIV programmes in the region.
By Arlette Campbell White GLOBAL FUND TO BENEFIT FROM “BREAKTHROUGH” ARV PRICING AGREEMENT
ABSTRACT
As a result of a pricing agreement between the Bill and Melinda Gates Foundation and two generic drug companies, starting in 2018 a state-of-the-art fixed dose combination ARV regimen will be available in 92 developing nations at a maximum cost of $75 per patient per year. The Global Fund was one of several organizations that worked on the agreement.
Financial Developments
ABSTRACT
The Gates Foundation announced a new pledge of $50 million for the Fund. No other new pledges were announced during the conference. Kofi Annan has agreed, if asked, to co-chair the Global Fund's Replenishment Conference next year, and to attend the Fund's November board meeting.
You've reached the end of the list.
